Nyse Tmbr News Today

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (

Timber Pharmaceuticals (NYSE:TMBR – Get Free Report) and Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of […]

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...

Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating) shares were up 1.4% during mid-day trading on Wednesday . The stock traded as high as $1.42 and last traded at $1.40. Approximately 23,453 shares changed hands during trading, a decline of 97% from the average daily volume of 811,045 shares. The stock had previously closed at $1.38. […]

Timber Pharmaceuticals (NYSE:TMBR – Get Rating) and Seres Therapeutics (NASDAQ:MCRB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk. Profitability This table compares Timber Pharmaceuticals and Seres Therapeutics’ […]

Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating) – Equities research analysts at HC Wainwright raised their Q1 2023 earnings estimates for shares of Timber Pharmaceuticals in a note issued to investors on Monday, April 10th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($1.17) per share for the quarter, […]

HC Wainwright restated their buy rating on shares of Timber Pharmaceuticals (NYSE:TMBR – Get Rating) in a research note issued to investors on Monday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. HC Wainwright also issued estimates for Timber Pharmaceuticals’ Q1 2023 earnings at ($1.17) EPS, Q2 2023 earnings […]

Timber Pharmaceuticals (NYSE:TMBR – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research note issued on Monday, Benzinga reports. They currently have a $11.00 price objective on the stock. HC Wainwright also issued estimates for Timber Pharmaceuticals’ Q1 2024 earnings at ($0.49) EPS, Q2 2024 earnings at ($0.42) EPS, Q3 […]

Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating) shares traded down 1.8% during trading on Monday . The stock traded as low as $1.65 and last traded at $1.67. 17,821 shares were traded during trading, a decline of 98% from the average session volume of 1,067,059 shares. The stock had previously closed at $1.70. Timber Pharmaceuticals […]

Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating)’s share price traded down 1.8% during trading on Monday . The company traded as low as $1.65 and last traded at $1.67. 17,821 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 1,067,059 shares. The stock had previously closed at $1.70. […]